These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

956 related items for PubMed ID: 7518259

  • 1. Cytokeratin 19 fragment CYFRA 21-1 compared with carcinoembryonic antigen, squamous cell carcinoma antigen and neuron-specific enolase in lung cancer. Results of an international multicentre study.
    Ebert W, Dienemann H, Fateh-Moghadam A, Scheulen M, Konietzko N, Schleich T, Bombardieri E.
    Eur J Clin Chem Clin Biochem; 1994 Mar; 32(3):189-99. PubMed ID: 7518259
    [Abstract] [Full Text] [Related]

  • 2. Optimal combination of seven tumour markers in prediction of advanced stage at first examination of patients with non-small cell lung cancer.
    Ando S, Kimura H, Iwai N, Shima M, Ando M, Kuriyama T.
    Anticancer Res; 2001 Mar; 21(4B):3085-92. PubMed ID: 11712815
    [Abstract] [Full Text] [Related]

  • 3. Pro-gastrin-releasing peptide (ProGRP), neuron specific enolase (NSE), carcinoembryonic antigen (CEA) and cytokeratin 19-fragments (CYFRA 21-1) in patients with lung cancer in comparison to other lung diseases.
    Schneider J, Philipp M, Velcovsky HG, Morr H, Katz N.
    Anticancer Res; 2003 Mar; 23(2A):885-93. PubMed ID: 12820318
    [Abstract] [Full Text] [Related]

  • 4. Assessment of serum CYFRA 21-1 in lung cancer.
    Muraki M, Tohda Y, Iwanaga T, Uejima H, Nagasaka Y, Nakajima S.
    Cancer; 1996 Apr 01; 77(7):1274-7. PubMed ID: 8608502
    [Abstract] [Full Text] [Related]

  • 5. Evaluation of Cyfra 21-1 as a marker for lung cancer.
    Najemnik C, Mohn-Staudner A, Vetter H, Kokron O, Baumgartner G, Scheiner W, Zwick H, Koderhold G, Alth G, Dudczak R.
    Wien Klin Wochenschr; 1996 Apr 01; 108(15):467-72. PubMed ID: 8806188
    [Abstract] [Full Text] [Related]

  • 6. [Diagnostic value of pleural effusion carcinoembryonic antigen, squamous cell carcinoma related antigen and neuron-specific-enolase in patients with lung cancer].
    Fujii M, Kiura K, Kamei H, Segawa Y.
    Nihon Kyobu Shikkan Gakkai Zasshi; 1988 May 01; 26(5):519-23. PubMed ID: 2852270
    [No Abstract] [Full Text] [Related]

  • 7. Tissue polypeptide specific antigen (tps) and cytokeratin 19 fragment (CYFRA 21.1) immunoradiometric assay in non small cell lung cancer evaluation.
    Giovanella L, Ceriani L, Bandera M, Rimoldi R, Beghé B, Roncari G.
    Q J Nucl Med; 1995 Dec 01; 39(4):285-9. PubMed ID: 8624791
    [Abstract] [Full Text] [Related]

  • 8. Value of tumour and inflammatory markers in lung cancer.
    Oremek GM, Sauer-Eppel H, Bruzdziak TH.
    Anticancer Res; 2007 Dec 01; 27(4A):1911-5. PubMed ID: 17649794
    [Abstract] [Full Text] [Related]

  • 9. Utility of serum cytokeratin 19 fragment (CYFRA 21-1) and carcinoembryonic antigen (CEA) as tumour markers for non-small cell lung cancer.
    Chantapet P, Riantawan P, Lebnak P, Getngern P.
    J Med Assoc Thai; 2000 Apr 01; 83(4):383-91. PubMed ID: 10808698
    [Abstract] [Full Text] [Related]

  • 10. Utility of the serum tumor markers: CYFRA 21.1, carcinoembryonic antigen (CEA), and squamous cell carcinoma antigen (SCC) in squamous cell lung cancer.
    Tas F, Aydiner A, Topuz E, Yasasever V, Karadeniz A, Saip P.
    J Exp Clin Cancer Res; 2000 Dec 01; 19(4):477-81. PubMed ID: 11277326
    [Abstract] [Full Text] [Related]

  • 11. Does the assessment of serum markers in patients with lung cancer aid in the clinical decision making process?
    Ebert W, Muley T, Drings P.
    Anticancer Res; 1996 Dec 01; 16(4B):2161-8. PubMed ID: 8694537
    [Abstract] [Full Text] [Related]

  • 12. [Tumor markers in lung cancer].
    Niho S, Shinkai T.
    Gan To Kagaku Ryoho; 2001 Dec 01; 28(13):2089-93. PubMed ID: 11791391
    [Abstract] [Full Text] [Related]

  • 13. Clinical relevance of thymidine kinase for the diagnosis, therapy monitoring and prognosis of non-operable lung cancer.
    Holdenrieder S, Von Pawel J, Duell T, Feldmann K, Raith H, Schollen A, Nagel D, Stieber P.
    Anticancer Res; 2010 May 01; 30(5):1855-62. PubMed ID: 20592392
    [Abstract] [Full Text] [Related]

  • 14. Tumour markers CEA, NSE, SCC, TPA and CYFRA 21.1 in resectable non-small cell lung cancer.
    Foa P, Fornier M, Miceli R, Seregni E, Santambrogio L, Nosotti M, Cataldo I, Sala M, Caldiera S, Bombardieri E.
    Anticancer Res; 1999 May 01; 19(4C):3613-8. PubMed ID: 10629660
    [Abstract] [Full Text] [Related]

  • 15. [Clinical investigation of neuron-specific enolase, squamous cell carcinoma-related antigen and carcinoembryonic antigen in carcinoma of the lung].
    Tashiro T, Nagai H, Yamasaki H, Kuroda Y, Goto Y, Goto J, Nasu M.
    Gan To Kagaku Ryoho; 1986 Jul 01; 13(7):2383-8. PubMed ID: 3015044
    [Abstract] [Full Text] [Related]

  • 16. Carcinoembryonic antigen, neuron-specific enolase and cytokeratin fragment 19 (CYFRA 21-1) levels in induced sputum of lung cancer patients.
    Hillas G, Moschos C, Dimakou K, Vlastos F, Avgeropoulou S, Christakopoulou I, Rasidakis A, Bakakos P.
    Scand J Clin Lab Invest; 2008 Jul 01; 68(7):542-7. PubMed ID: 19378425
    [Abstract] [Full Text] [Related]

  • 17. [Clinical and prognostic significance of tumor markers cytokeratin 19 fragment, carcinoembryonic antigen, and neuron-specific enolase in lung cancer].
    Zemaitis M, Sakalauskas R, Malakauskas K, Muley T, Fischer JR, Lahm H.
    Medicina (Kaunas); 2005 Jul 01; 41(7):566-76. PubMed ID: 16062024
    [Abstract] [Full Text] [Related]

  • 18. [Measurement of carcinoembryonic antigen, squamous cell carcinoma related antigen and neuron-specific enolase in the bronchoalveolar lavage fluid in patients with peripheral lung cancer].
    Fujii M, Kiura K, Kamei H, Segawa Y.
    Nihon Kyobu Shikkan Gakkai Zasshi; 1989 Apr 01; 27(4):452-5. PubMed ID: 2552209
    [Abstract] [Full Text] [Related]

  • 19. [In suspected bronchial cancer are the tumor markers neuron-specific enolase, carcinoembryonic antigen and squamous cell carcinoma antigen, of diagnostic help?].
    Jany B, Fischbach W, Chowanetz W.
    Med Klin (Munich); 1988 Feb 26; 83(4):121-4, 158. PubMed ID: 3367874
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 48.